Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2108 (LINC02108)

Target
LINC02108
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2108 (LINC02108; also known as CTD-2117L12.1) is classified as a long intergenic non-coding RNA (lincRNA), a subclass of long non-coding RNAs (lncRNAs)[1][3]. LincRNAs are defined as RNA transcripts longer than 200 nucleotides that do not overlap with any protein-coding genes[1][3]. They primarily function in the nucleus, where they regulate gene expression through various mechanisms such as chromatin remodeling, transcriptional regulation, and RNA stabilization[1][7]. LincRNAs can also act as scaffolds for protein complexes involved in epigenetic regulation[1][7]. While many lincRNAs have been implicated in various physiological and pathological processes, there is currently no specific evidence that LINC02108 serves as a validated therapeutic target or has direct drug interactions. Its biological and disease relevance, like many lincRNAs, remains an area of ongoing research[1][3][7].

Other names
CTD-2117L12.1LINC02108
02

Biological functions

Regulation of gene expressionChromatin remodelingTranscription regulationRNA stabilization
03

Disease associations

Other (no documented direct involvement in specific disease categories as of current knowledge, but lincRNAs in general can play roles in diseases, especially cancers)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2108 (LINC02108).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2108 (LINC02108).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call